- Home
- CLLS vs SRG Comparison
CLLS vs SRG Comparison
Compare CLLS & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SRG
- Stock Information
- Founded
- CLLS 1999
- SRG 2014
- Country
- CLLS France
- SRG United States
- Employees
- CLLS N/A
- SRG N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SRG Real Estate Investment Trusts
- Sector
- CLLS Health Care
- SRG Real Estate
- Exchange
- CLLS Nasdaq
- SRG Nasdaq
- Market Cap
- CLLS 164.2M
- SRG 238.6M
- IPO Year
- CLLS 2007
- SRG 2015
- Fundamental
- Price
- CLLS $1.69
- SRG $4.13
- Analyst Decision
- CLLS Buy
- SRG
- Analyst Count
- CLLS 3
- SRG 0
- Target Price
- CLLS $7.00
- SRG N/A
- AVG Volume (30 Days)
- CLLS 54.8K
- SRG 273.7K
- Earning Date
- CLLS 11-04-2024
- SRG 11-12-2024
- Dividend Yield
- CLLS N/A
- SRG N/A
- EPS Growth
- CLLS N/A
- SRG N/A
- EPS
- CLLS N/A
- SRG N/A
- Revenue
- CLLS $36,042,000.00
- SRG $56,359,000.00
- Revenue This Year
- CLLS $271.02
- SRG N/A
- Revenue Next Year
- CLLS $33.48
- SRG N/A
- P/E Ratio
- CLLS N/A
- SRG N/A
- Revenue Growth
- CLLS 46.96
- SRG N/A
- 52 Week Low
- CLLS $1.41
- SRG $3.63
- 52 Week High
- CLLS $3.38
- SRG $9.87
- Technical
- Relative Strength Index (RSI)
- CLLS 36.61
- SRG 44.52
- Support Level
- CLLS $1.41
- SRG $3.98
- Resistance Level
- CLLS $1.64
- SRG $4.25
- Average True Range (ATR)
- CLLS 0.10
- SRG 0.15
- MACD
- CLLS -0.03
- SRG -0.01
- Stochastic Oscillator
- CLLS 19.09
- SRG 28.45
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management and leasing of diversified and mixed-use properties throughout the United States.